Results 31 to 40 of about 162,806 (305)

Canine reference intervals for coagulation markers using the STA Satellite and the STA-R Evolution analyzers [PDF]

open access: yes, 2010
The aim of the current study was to determine canine reference intervals for prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen, and antithrombin (AT) according to international recommendations. The STA Satellite coefficients
Braun, Jean-Pierre   +5 more
core   +1 more source

Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study

open access: yesCancer Medicine, 2021
The previous retrospective study suggested that dosing vitamin K may enhance the anticancer action of sorafenib against hepatocellular carcinoma. To confirm it, we performed a phase II, randomized, open‐label study. Patients with hepatocellular carcinoma
Yoshimichi Haruna   +2 more
doaj   +1 more source

Air temperature and inflammatory and coagulation responses in men with coronary or pulmonary disease during the winter season [PDF]

open access: yes, 2010
Background and Objective Air temperature changes are associated with increased cardiovascular and respiratory risk, but the roles of inflammatory and coagulation markers are not well understood.
Breitner, Susanne   +8 more
core   +1 more source

Factor V G1691A (Leiden) is a major etiological factor in Egyptian Budd-Chiari syndrome patients

open access: yesTurkish Journal of Hematology, 2011
OBJECTIVE: Budd-Chiari syndrome is a multifactorial disease in which several prothrombotic disorders may predispose patients to the development of thrombosis at this uncommon location (hepatic veins). The aim of this study was to determine the prevalence
Tawhida Y. Abdel Ghaffar   +7 more
doaj   +3 more sources

Inherited thrombophilia and portal vein thrombosis in cirrhosis: A systematic review and meta‐analysis

open access: yesResearch and Practice in Thrombosis and Haemostasis, 2019
Background Portal vein thrombosis (PVT) is common in cirrhosis. PVT is associated with high morbidity and mortality. Individual reports suggest that PVT occurs more frequently in patients with cirrhosis and inherited thrombophilia.
Steven D. Ma   +5 more
doaj   +1 more source

Current perspective of venous thrombosis in the upper\ud extremity [PDF]

open access: yes, 2008
Venous thrombosis of the upper extremity is a rare disease. Therefore, not as much is known about risk factors, treatment and the risk of recurrence as for venous thrombosis of the leg.
Doggen, C.J.M.   +3 more
core   +3 more sources

Evaluation of Dr. Szirmai's method of treating thrombosis with neomyograms resp. neomyographs [PDF]

open access: yes, 1961
Neomyographic examinations were made by the authors on 28 patients. The extent of reconvalescence was measured on the basis of changes in the values recorded by the myograms taken before and after the treatment.
Haberl, A., Juranyi, R.
core   +1 more source

Association of Factor V Leiden and Prothrombin G20210A Polymorphisms in Women with Recurrent Pregnancy Loss in Isfahan Province, Iran

open access: yesInternational Journal of Preventive Medicine, 2018
Background: Maternal thrombophilia has been identified as a risk factor for recurrent pregnancy loss (RPL). The aim of this study was to investigate the association between prothrombin G20210A and factor V Leiden (FVL) polymorphisms in women with RPL and
Mohammad Taghi Kardi   +3 more
doaj   +1 more source

Crotalus atrox venom preconditioning increases plasma fibrinogen and reduces perioperative hemorrhage in a rat model of surgical brain injury. [PDF]

open access: yes, 2017
Perioperative bleeding is a potentially devastating complication in neurosurgical patients, and plasma fibrinogen concentration has been identified as a potential modifiable risk factor for perioperative bleeding.
Applegate, Richard   +12 more
core   +1 more source

Patients with Essential thrombocythaemia have an increased prevalence of antiphospholipid antibodies which may be associated with thrombosis [PDF]

open access: yes, 2002
A significant proportion of patients with Essential Thrombocythaemia (ET) have thrombotic complications which have an important impact upon the quality, and duration of their life.
Carr, P.   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy